Education

ISGO and Education

The European Society of Gynaecological Oncology (ESGO) produce European guidelines for the diagnosis and treatment of gynaecological cancers many of which are adopted by irish centres.
 
ESGO also accredits and assess units for surgical expertise and training. Therefore the ISGO advises all clinicians working in gynaecological oncology to become ESGO members and utilise the extensive educational material available on the ESGO website. Many ISGO members are also active members of the International Gynaecological Cancer Society (IGCS) and partake in many of their global outreach activities.
 
The IGCS website also contains many excellent educational aids and video’s and clincians in Ireland working in this area should also consider joining the IGCS.
 
 

Nationally

Each year the ISGO holds a national conference. In November 2021 the conference was hosted in Cork. It was a hybrid conference, a mix of in person and virtual presentations. The following are some of the talks that were presented on the day.
 

Horizon scanning the future treatment in cervical cancer 

Dr Dearbhaile Collins, Consultant Oncologist Cork University Hospital

Role of HIPEC in gynaecological malignancies 

Prof Donal Brennan Consultant Gynaecological Oncologist Mater Misericordiae University Hospital

Communicating about my cancer in challenging times: What helps and what doesn’t 

Dr Helen Greely Director of psychology and support services, Cancer Care West/National lead for psycho-oncology

Women’s Health Initiative update 

Ms Yvonne O’Meara Women’s cancer survivorship cancer research coordinator Mater Misericordiae University Hospital

Women’s Health Initiative update 

Ms Kate O’Connell, Research support officer, Cork University Hospital

OncoGenetics in Gynae Cancer 

Dr Karen Cadoo, Consultant Medical Oncologist, St James’s Hospital Dublin

Hot Topics in Menopause 

Dr Fionan Donohoe Clinical Fellow Living Well Cancer Programme Mater Misericordiae University Hospital

Covid Impact on gynaecological cancers 

Prof Seamus O’Reilly  Consultant medical oncologist, Cork University Hospital

 

n

thisisgo.ie

The platform (on-line portal) which was developed ‘by patients for patients’ in partnerships with healthcare professionals, was launched in Sept 2021 and is aiming to change the landscape in how we support those with gynaecological cancers, including cervical, ovarian, endometrial, vulval and vaginal cancers. It also has a planned portal for those impacted by hereditary cancers such as BRCA and Lynch Syndrome. It is hoped that by the end of  2022 the site will be finished.

Currently there are still significant deficits in the provision of information and support for women affected by gynaecological cancer the team at thisisGO.ie are working, whilst acknowledging the power of cooperation and collection action, to provide this one-stop shop for these women, their families and Health Care Providers via thisisGO.ie

The platform includes over 140 different articles, videos, podcasts, useful resources, symptom tracker, decoding the science and service directory content. These materials address every stage of the specific cancer diagnosis, treatment and life with and after this cancer. The platform also supports Health Care Professionals in their clinical practice, offering useful articles such as How to Break Bad News and How to take a Sexual History from a Patient.’

thisisGO.ie is kindly supported by the Irish Cancer Society through its Women’s Health Initiative and by UCD Clinical Research Centre (CRC), OvaCare, GSK, Pfizer and patient donations.

Please see https://thisisgo.ie/

 

 

ISGO ANNUAL MEETING: CPD

Attendees from the ISGO Annual Meeting 2023 can access the CPD certificate here:

Support ISGO

Thank you so much for your kind donation. The Irish Society of Gynaecological Oncology is a collaboration between medical professionals who care for patients with women’s cancers, patients and their advocates.

We strive to improve access to quality healthcare and vital research in gynaecological cancers. Thanks to your donation, we can continue to work towards a better future for Irish patients with gynaecological cancers.